Compounds > ethylenediamine-n,n'-bis(2-hydroxyphenylacetic acid)
Page last updated: 2024-08-21

ethylenediamine-n,n'-bis(2-hydroxyphenylacetic acid) and Bronze Diabetes

ethylenediamine-n,n'-bis(2-hydroxyphenylacetic acid) has been researched along with Bronze Diabetes in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brown, EB1
Metterville, JJ; Rosenkrantz, H1

Reviews

1 review(s) available for ethylenediamine-n,n'-bis(2-hydroxyphenylacetic acid) and Bronze Diabetes

ArticleYear
Recognition and treatment of iron overload.
    Advances in internal medicine, 1980, Volume: 26

    Topics: Adult; Blood Grouping and Crossmatching; Bloodletting; Costs and Cost Analysis; Deferoxamine; Ethylenediamines; Female; Ferritins; Hemochromatosis; Humans; Iron; Iron Chelating Agents; Liver; Male; Thalassemia; Transferrin; Transfusion Reaction

1980

Other Studies

1 other study(ies) available for ethylenediamine-n,n'-bis(2-hydroxyphenylacetic acid) and Bronze Diabetes

ArticleYear
Iron tissue and excreta changes induced by ethylenediamine-N,N'-bis(2-hydroxyphenylacetic acid) in dogs.
    The Journal of laboratory and clinical medicine, 1980, Volume: 95, Issue:5

    Topics: Animals; Dogs; Dose-Response Relationship, Drug; Drug Evaluation; Ethylenediamines; Feces; Female; Hemochromatosis; Iron; Kidney; Lethal Dose 50; Male

1980